D&D Pharmatech logo

D&D Pharmatech

Asia, Kyonggi-do, South Korea, Seongnam

Description

D&D Pharmatech is a Health care Company.

Investor Profile

D&D Pharmatech has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does D&D Pharmatech frequently co-invest with?

LB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Smilegate Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Geon Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
OL
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
DongKoo Bio&Pharma
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Maryland Venture Fund
North America, Maryland, United States, Columbia
Co-Investments: 1
I
North America, Washington, United States, Kirkland
Co-Investments: 1
Magna Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by D&D Pharmatech?

Neuraly

Germantown, Maryland, United States

Neuraly is a startup biotech company.

BiotechnologyHealth Care
Series AJul 18, 2018
Amount Raised: $36,000,000